Agilent gets fda approval for pd-l1 companion diagnostic on dako omnis

Agilent receives fda approval for pd-l1 companion diagnostic on dako omnis.agilent technologies inc - fda approved co's pd-l1 ihc 22c3 pharmdx as a companion diagnostic to identify patients with non-small cell lung cancer.
A Ratings Summary
A Quant Ranking